Inventor · disambiguated record
Kristi Elkins
Also filed as: ELKINS KRISTI
16 granted patents·9 pending applications·273 citations·filing 2008–2023
95Inventor score
Top patents by PatentIndex Score
25 records- 0197US8545850B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2010·Granted Oct 1, 2013·48 cites·8 claims
- 0296US8088378B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2008·Granted Jan 3, 2012·48 cites·5 claims
- 0395US9896506B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2015·Granted Feb 20, 2018·17 cites·27 claims
- 0495US8617559B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Dec 31, 2013·19 cites·34 claims
- 0594US8722857B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2009·Granted May 13, 2014·22 cites·53 claims
- 0694US8691531B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2011·Granted Apr 8, 2014·20 cites·9 claims
- 0794US8362213B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2010·Granted Jan 29, 2013·28 cites·53 claims
- 0892US10981987B2Humanized anti-CD79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2017·Granted Apr 20, 2021·4 cites·26 claims
- 0992US9845355B2Humanized anti-CD79b antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2008·Granted Dec 19, 2017·20 cites·23 claims
- 1092US8466260B2Anti-FcRH5 antibodies and immunoconjugates and methods of useELKINS KRISTI·Filed 2010·Granted Jun 18, 2013·21 cites·49 claims
- 1191USRE48558EAnti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2018·Granted May 18, 2021·2 cites·70 claims
- 1291US9360484B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Jun 7, 2016·7 cites·20 claims
- 1389US11866496B2Humanized anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2021·Granted Jan 9, 2024·1 cites·31 claims
- 1489US2024309088A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1588US10544218B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2016·Granted Jan 28, 2020·4 cites·61 claims
- 1686US10494432B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Dec 3, 2019·5 cites·118 claims
- 1785US9017951B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Apr 28, 2015·7 cites·1 claims
- 1882US2022251197A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2022·Application pending·0 cites
- 1976US2020247887A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 2069US2020079852A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 2164US2014335107A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2262US2009068178A1Compositions and Methods for the Treatment of Tumor of Hematopoietic OriginGENENTECH INC·Filed 2008·Application pending·0 cites
- 2356US2017362318A1Compositions and methods for the treatment of tumor hematopoietic originGENENTECH INC·Filed 2017·Application pending·0 cites
- 2449US2011206658A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 2548US2011070243A1Compositions and methods for the treatment of tumor of hematopoieticCROWLEY CRAIG·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →